FDA Clears Blood Test For Alzheimer’s Co-Developed By Lilly

The U.S. Food and Drug Administration has cleared a blood test developed by Roche and Eli Lilly and Co. to help assess amyloid pathology associated with Alzheimer’s disease in people 55 and older experiencing signs of cognitive decline.